For instance, Sun et al. observed that curcumin administration in a colitis model significantly reduced immune cell recruitment and pro-inflammatory cytokines, demonstrating its potential as a therapeutic agent through OPN inhibition [149]. The gene discussed is SPP1; the disease is colitis.